In addition, dual targeting of GLI1 by arsenic trioxide and PI3K inhibitor LY294002 synergistically downregulated both the GLI1 protein level and GLI1 target genes BCL2 and CCND1, which resulted in decreased proliferarion of colon cancer cells [213]. This evidence concerns the gene GLI1 and malignant colon neoplasm.